Short Interest in Nascent Biotech, Inc. (OTCMKTS:NBIO) Rises By 789.2%

Nascent Biotech, Inc. (OTCMKTS:NBIOGet Rating) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 32,900 shares, an increase of 789.2% from the March 31st total of 3,700 shares. Based on an average daily volume of 825,400 shares, the days-to-cover ratio is currently 0.0 days.

Shares of OTCMKTS NBIO traded up $0.00 during mid-day trading on Wednesday, reaching $0.13. The company had a trading volume of 169,132 shares, compared to its average volume of 151,821. The company has a 50-day moving average price of $0.07 and a two-hundred day moving average price of $0.07. Nascent Biotech has a 1-year low of $0.04 and a 1-year high of $0.13.

Nascent Biotech (OTCMKTS:NBIOGet Rating) last released its quarterly earnings data on Monday, February 14th. The company reported $0.01 earnings per share (EPS) for the quarter. The firm had revenue of $1.00 million for the quarter.

About Nascent Biotech (Get Rating)

Nascent Biotech, Inc, a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a monoclonal antibody to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as lung and breast cancer metastases to the brain; and pancreatic cancer.

See Also

Receive News & Ratings for Nascent Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nascent Biotech and related companies with MarketBeat.com's FREE daily email newsletter.